Document Type : Clinical Notes

Authors

Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Abstract

-

Keywords

  1. Montoya JP, Pena A, Sobrino FE, et al. Central and peripheral nervous system involvement by COVID-19: A systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect Dis 2021; 21(1): 515.
  2. Parsons T, Banks S, Bae C, Gelber J, Alahmadi H, Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol 2020; 267(10): 2799-802.
  3. Notarte KI, Senanayake S, Macaranas I, Albano PM, Mundo L, Fennell E, et al. MicroRNA and other non-coding RNAs in Epstein-Barr virus-associated cancers. Cancers (Basel) 2021; 13(15): 3909.
  4. Kennedy PGE, Mogensen TH. Varicella-Zoster virus infection of neurons derived from neural stem cells. Viruses 2021; 13(3): 485.
  5. Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep 2016; 13(4): 3391-6.
  6. Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 2022; 375(6578): 296-301.
  7. Mechelli R, Romano C, Reniè R, Manfrè G, Buscarinu MC, Romano S, et al. Viruses and neuroinflammation in multiple sclerosis. Neuroimmunol Neuroinflamm 2021; 8: 269.
  8. Friedman JE, Lyons MJ, Cu G, Ablashl DV, Whitman JE, Edgar M, et al. The association of the human herpesvirus-6 and MS. Mult Scler 1999; 5(5): 355-62.
  9. Talbot PJ, Boucher A, Duquette P, Gruslin E. Coronaviruses and Neuroantigens: myelin proteins, myelin genes. In: Lavi E, Constantinescu CS, editors. Experimental models of multiple sclerosis. Boston, MA: Springer US; 2005. p. 781-91.
  10. Petkovic F, Castellano B. The role of interleukin-6 in central nervous system demyelination. Neural Regen Res 2016; 11(12): 1922-3.
  11. Satheesh NJ, Salloum-Asfar S, Abdulla SA. The potential role of COVID-19 in the pathogenesis of multiple sclerosis-a preliminary report. Viruses 2021; 13(10): 2091.
  12. Karsidag S, Sahin S, Ates MF, Cinar N, Kendirli S. demyelinating disease of the central nervous system concurrent with COVID-19. Cureus 2021; 13(8): e17297.
  13. Yavari F, Raji S, Moradi F, Saeidi M. demyelinating changes alike to multiple sclerosis: A case report of rare manifestations of COVID-19. Case Rep Neurol Med 2020; 2020: 6682251.
  14. Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K, et al. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 2020; 162(7): 1491-4.
  15. Sarwar S, Rogers S, Mohamed AS, Ogula E, Ayantayo RA, Ahmed A, et al. Multiple sclerosis following SARS-CoV-2 infection: A case report and literature review. Cureus 2021; 13(10): e19036.
  16. Naser Moghadasi A. A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis. Autoimmun Rev 2021; 20(5): 102803.
  17. Palao M, Fernandez-Diaz E, Gracia-Gil J, Romero-Sanchez CM, Diaz-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord 2020; 45: 102377.
  18. Ismail II, Al-Hashel J, Alroughani R, Ahmed SF. A case report of multiple sclerosis after COVID-19 infection: Causality or coincidence? Neuroimmunology Reports 2021; 1: 100008.
  19. Moore L, Ghannam M, Manousakis G. A first presentation of multiple sclerosis with concurrent COVID-19 infection. eNeurologicalSci 2021; 22: 100299.